Historical record - last NADAC effective date: 3/18/2020

Product Information

PYRIDOSTIGMINE BR 60 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3756 per EA under NDC 68382065901. Its NADAC has been published 233 times since Oct 14, 2015.

FDA first approved this application on Jun 22, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PYRIDOSTIGMINE BR 60 MG TABLET

pyridostigmine bromide
$0.3756per EA

Strength

60 mg/1

NDC

68382065901

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

3/18/2020

Active Ingredients

PYRIDOSTIGMINE BROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205650

FDA Approved

6/22/2015

TE Code

AB

On Market Since

8/7/2015

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has been published 233 times since Oct 14, 2015, and over the history we have for it it has declined 42.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3756 per EA
All-time high$0.6549 (Oct 14, 2015)
All-time low$0.3671 (Jan 22, 2020)
Median price$0.4910
Average price$0.4893
Largest weekly change-14.6% (Apr 18, 2018)
Weeks tracked233
Tracking sinceOct 14, 2015

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-42.6%

Last surveyed Mar 25, 2020 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PYRIDOSTIGMINE BR 60 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PYRIDOSTIGMINE BR 60 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3756 per EA (NDC 68382065901), effective Mar 25, 2020.

How has the price of PYRIDOSTIGMINE BR 60 MG TABLET changed over time?

Over the history we have for it, the NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has declined 42.6%. It has been tracked across 233 weekly CMS publications since Oct 14, 2015.

What are the highest and lowest recorded NADAC prices for PYRIDOSTIGMINE BR 60 MG TABLET?

Since Oct 14, 2015, the NADAC for PYRIDOSTIGMINE BR 60 MG TABLET has ranged from a low of $0.3671 (Jan 22, 2020) to a high of $0.6549 (Oct 14, 2015), with a median of $0.4910 per EA.

Are there cheaper alternatives to PYRIDOSTIGMINE BR 60 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PYRIDOSTIGMINE BR 60 MG TABLET, is $0.2649 per EA — about 29% below PYRIDOSTIGMINE BR 60 MG TABLET.

Who manufactures PYRIDOSTIGMINE BR 60 MG TABLET?

PYRIDOSTIGMINE BR 60 MG TABLET (NDC 68382065901) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.